Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance-Reference-Cited by-同舟云学术

Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance

Published:2010-02-15 Issue:3 Volume:89 Page:320-326
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

van der Beek Martha T.,Berger Stefan P.,Vossen Ann C. T. M.,van der Blij-de Brouwer Caroline S.,Press Rogier R.,de Fijter Johan W.,Claas Eric C. J.,Kroes Aloys C. M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.;Hibberd;Transplantation,1992

2. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients.;Rondeau;Nephrol Dial Transplant,1993

3. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: A systematic review.;Sun;Am J Transplant,2008

4. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients.;Khoury;Am J Transplant,2006

5. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial.;Kliem;Am J Transplant,2008

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance;Clinical Transplantation;2024-09

2. Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan;Journal of the Formosan Medical Association;2024-05

3. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir;Infectious Disease Reports;2024-01-18

4. Quantitative Viral Load Monitoring;Advances in Molecular Pathology;2023-11

5. A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients;Transplantation Direct;2023-07-12